Skip to main content

Advertisement

Table 1 Baseline Patient Characteristics

From: Neoadjuvant irinotecan, cisplatin, and concurrent radiation therapy with celecoxib for patients with locally advanced esophageal cancer

Characteristic Total (N = 40)
Age
 Median 65 years
 Range 37 to77 years
Gender
 Male 34 (85 %)
 Female 6 (15 %)
Performance Status
 ECOG 0 19 patients (48 %)
 ECOG 1 21 patients (52 %)
Pathology
 Adenocarcinoma 34 patients (85 %)
 Squamous carcinoma 6 patients (15 %)
Stage (AJCC 5th edition)
 Stage IIA 12 patients (30 %)
 Stage IIB 8 patients (20 %)
 Stage III 9 patients (22.5 %)
 Stage IVA 11 patients (27.5 %)
Tumor Location
 Middle Esophagus 7 patients (17.5 %)
 Lower Esophagus 23 patients (57.5 %)
 Gastroesophageal Junction 10 patients (25 %)
Dysphagia (Grade ≥1) 34 patients (85 %)
Greater than 10 % weight loss 10 patients (25 %)